New hope for rare skin disease: experimental drug EPN-701 enters phase 2 trial
Disease control
Not yet recruiting
This study tests a new drug, EPN-701, for calciphylaxis, a rare condition causing painful skin sores with no approved treatment. About 60 adults with moderate to severe pain will receive the drug to see if it reduces pain and shrinks sores. The goal is to gather safety and effect…
Phase: PHASE2 • Sponsor: Sagar U. Nigwekar, MD, MMSc • Aim: Disease control
Last updated May 22, 2026 13:54 UTC